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level of temporal persistence over 5 years and predict symp-
tomatic outcome.
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Background
The first reports in contemporary psychiatry pointing to a 
disorder of the self appeared at the turn of the millennium 
[18, 25]. The main idea from these studies was that a disor-
der of the self is the core feature of schizophrenia-spectrum 
disorders. It was not a novel insight, but can be found in 
nearly all foundational texts on schizophrenia [1, 2, 10, 14, 
17, 31].
It is postulated that the affected structure is the ‘mini-
mal’ or ‘core’ self, which enables us to experience ourselves 
as self-same subjects who experience the world from our 
own first-person perspective [3, 6]. It means that we have 
an immediate, but tacit sense of bodily self-presence, and 
all our mental states are imbued with a sense of subjectiv-
ity. In schizophrenia-spectrum disorders this sense-of-self 
becomes weakened, often leading to hyperreflectivity and 
a feeling of being ephemeral, not fully existing. One’s field 
of experience (e.g., thoughts or sensations) may be felt as 
increasingly distant and spatialized (e.g., thoughts are expe-
rienced as physical objects) [30].
In 2005, a scale (Examination of Anomalous Self Expe-
riences—EASE) targeting a range of anomalous self-
experiences indicative of the basic self-disorder was pub-
lished [26]. Since the publication, several research groups 
have used this scale to explore anomalies of self-experi-
ence in schizophrenia-spectrum disorders, ultra high-risk 
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populations, unselected help-seeking adolescents, and the 
general population [8, 13, 19, 21, 27, 29].
We have previously reported temporal persistence of self-
disorders measured by an early precursor of the EASE [20]. 
However, no reports of the persistence of EASE-measured 
abnormalities have yet been published. This issue is of theo-
retical and clinical importance; if we consider the underly-
ing self-disorder as a core trait feature of the schizophrenia-
spectrum, then we would expect some degree of stability of 
the abnormal phenomena.
Aim of the study
In this study, we examined EASE-measured self-disorders 
(SD) in a sample of first-admission patients with schizo-
phrenia-spectrum disorders at admission and at a follow-up 
5 years later.
Methods
Sample
The original sample comprised 100 consecutive first-admis-
sion patients of a psychiatric facility in Copenhagen, for 
details see [21].
To be included in the study, the patients had to be consid-
ered capable of tolerating lengthy interviews, because one 
of the study goals was to examine the adequacy/efficacy of 
different psycho-diagnostic interview approaches [22]. This 
requirement naturally excluded aggressive, agitated, and/or 
severely psychotic patients. Additional exclusion criteria 
comprised primary or clinically dominating alcohol/sub-
stance abuse, history of brain injury, mental retardation, 
organic brain disorder, and age >65 years. Due to ethical 
concerns, involuntarily admitted and forensic patients were 
also excluded. This selection procedure resulted in a sam-
ple of comparatively “mildly” ill patients, yet still requiring 
hospital admission.
The follow-up took place 5 years later. We wished to re-
examine the patients who at the index evaluation received 
a ICD-10 schizophrenia-spectrum disorder diagnosis, i.e., a 
diagnosis of non-affective, non-organic psychosis, or schi-
zotypal disorder.
The patients participated on the condition of informed 
consent and a relevant Medical Ethical Committee approved 
the study.
Interviews and assessments
The details of the diagnostic assessments at baseline are 
published elsewhere [22, 23]. Briefly, at baseline all patients 
were interviewed with the SCID-I and the Schizotypal 
Personality Disorder module from the SCID-II [5], the 
OPCRIT-scale (an extract of the PSE) [16], expanded with 
additional items from the SADS-L [4], the EASE [26], per-
ceptual items from the BSABS [7], a checklist of the First 
Rank Symptom continua [12], and a Mental Status Exami-
nation [10, 11, 15]. Additionally, the patients were assessed 
with respect to life history, overall psychosocial function-
ing, family history of mental disorder, and the evolution of 
psychopathology.
The baseline timeframe for the assessment of self-dis-
orders were lifetime and at follow-up self-disorders were 
assessed within the last 18 months.
Finally, all patients were allocated a ‘Best-Estimate Con-
sensus Life-Time’ ICD-10 diagnosis and a ‘Best-Estimate 
Consensus Life-Time’ DSM-IV diagnosis by JP and JN, 
who jointly reviewed all available, diagnostically relevant 
information.
74 patients were diagnosed within the schizophrenia-
spectrum according to the ICD-10, 68 of these also fulfilled 
a DSM-IV diagnosis within the schizophrenia-spectrum.
At follow-up, the psychopathological assessment was 
identical to the baseline battery described above, except for 
the SCID being excluded. The interviewer at follow-up was 
blind with respect to detailed psychopathological informa-
tion from the index interviews.
The interviewer at follow-up (LSN) also allocated each 
participant a lifetime ICD-10 and a lifetime DSM-5 diagno-
sis. The interviewer was a clinical psychiatrist who had been 
trained in the application of the EASE instrument. More 
specifically, the inter-rater reliability between the baseline 
and follow-up interviewers was tested on 18 patients result-
ing in a Cohen’s kappa of 0.81.
In accordance with previous publications, we looked 
only for the presence or absence (not severity or duration) 
of the EASE items and explored the latter as dimensions 
(i.e., summing up the items rated as present, we only used 
main items). We scored 0 for absent or questionably present 
and 1 for present. We only included the main items and not 
sub-types in the analyses. The EASE shows a high degree of 
internal consistency (Chronbach’s alpha 0.903) [21].
Since we did not use the Positive and Negative Syndrome 
Scale (PANSS) in the baseline assessment to obtain these 
measures, we constructed proxy scales for positive and neg-
ative symptoms by adding nonoverlapping items selected 
from the interview schedule, for details see [21]. This proce-
dure was applied to both the baseline and the follow-up data.
Sample attrition
We only succeeded to obtain full personal interviews with 
48 subjects of the original group of 74 (65%). 12 declined to 
participate in the follow-up study, 12 were lost to follow-up, 
1 emigrated, and 1 was in forensic treatment.
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Data analysis
In all analyses, we used the ICD-10 diagnoses.
We tested for potential differences in the self-disorder 
scores between baseline and follow-up using mixed models 
and ANOVA adjusting for domain as a repeated variable. 
Because of questionable normal distribution of residuals 
tested by Shapiro–Wilks test, we also compared baseline and 
follow-up for the total EASE scores and for each of the five 
domains with the non-parametric Wilcoxon signed-rank test.
The correlations between baseline and follow-up were 
tested with Spearman’s rho, two-tailed.
We tested if baseline EASE score predicted GAF follow-
up by univariate linear regression.
Furthermore, we compared the baseline-remainders and 
the baseline-dropouts with Wilcoxon signed-rank test. We 
used Fischer’s exact test to test for independence between 
the variable for remainders/dropouts and (1) gender; (2) edu-
cational level; (3) marital status; and (4) diagnosis. We used 
the McNemar to test the independence between the variable 
for the baseline/follow-up and variable (2)–(4).
We used SPSS version 24, Stata version 14.1, and SAS 
version 9.4.
Results
Table 1 shows the differences for the following variables 
at baseline and follow-up, and for the 26 patients included 
at baseline, but not at follow-up (dropouts): gender; mari-
tal status; the diagnostic groups (non-affective psychosis or 
schizotypal personality disorder); educational level; age; 
self-disorders; Global Assessment of Functioning-Symptom 
scale (GAF-S); Global Assessment of Functioning-Function 
scale (GAF-F); and the positive and negative symptoms 
scales. The Wilcoxon signed-rank test results show that the 
mean for both GAF-S and GAF-F increased significantly 
(P < 0.0001) from baseline to follow-up, reflecting at bet-
ter level of functioning and a lower level of symptoms at 
follow-up.
Five patients (10.4%) changed diagnosis from schizotypal 
disorder to schizophrenia at the follow-up assessment.
Several of the patients completed further education and 
got married during the 5 years.
P values from the mixed analysis (0.13) and the ANOVA 
(0.13) adjusting for domain as repeated variable showed that 
the mean SD score can be assumed to be identical at the 
both occasions when we adjust for domain. Additionally, 
we tested the full EASE scale and each of the five domains 
independently of each other (due to questionably normal 
distributed residuals). The mean differences between SD at 
baseline and follow-up are also presented in Table 1. For the 
full EASE scale and for four of the five domains (domain 1, 
3, 4, and 5), it can be assumed that the mean SD score is the 
same at baseline and at follow-up. For domain 2, the mean 
score slightly increased at follow-up.
The 26 dropouts had a statistically significant lower level 
of SD at baseline than the 48 remainders.
Table 2 shows the correlation matrix for the EASE scale, 
the five EASE domains, and the GAF scores. We found a 
moderate (ρ = 0.484, P < 0.01) correlation between baseline 
and follow-up of the full EASE. Additionally, the correla-
tion between baseline SD and baseline GAF-S was moderate 
(ρ = −0.378, P < 0.01) and so was the correlation between 
baseline SD and follow-up GAF-S (ρ = −0.382, P < 0.01).
Correlations between the full EASE, and the positive and 
negative symptoms scales were not significant except for the 
correlation between positive symptoms and EASE at follow-
up (ρ = 0.530, P < 0.01). There was no temporal change in 
the level of positive symptoms and a slight increase in the 
level of negative symptoms.
In Table 3, the 13 most-frequently rated items at baseline 
are displayed. Additionally, the table shows the P value from 
the McNemar test (P values below 0.05 is in bold, indicat-
ing a significant difference between baseline and follow-up) 
and the frequencies of the items’ presence at baseline and at 
follow-up. Equal proportions at baseline and follow-up were 
found for 9 out of the 13 items.
Finally, baseline SD affected follow-up GAF-S [slope 
estimate −0.346 (95% CI 0.62; −0.07), P = 0.017]; thus, 
pointing to higher levels of SD at the initial assessment 
predicting higher symptomatic levels at follow-up (in this 
analysis, we omitted one subject who exhibited an extraordi-
nary outlier value which could not be adapted to the analytic 
model). There was no effect of baseline SD on GAF-F at the 
follow-up.
Discussion and conclusion
A limitation of this study is that we only succeeded to obtain 
follow-up interviews with 65% of the patients, but this fig-
ure corresponds to most follow-up studies. However, there 
were no differences with respect to standard global psycho-
pathological (positive and negative symptoms measures) or 
demographic characteristics between the participants and 
the dropouts.
To the best of our knowledge, this is the first report on the 
persistence of SD measured by the EASE across 5 years in a 
sample of schizophrenia-spectrum patients. The total level of 
SD at the two occasions was not statistically different. Look-
ing at the domains individually there was a minor increase 
for domain 2, measuring self-awareness and presence. This 
little increase may perhaps be ascribed to methodological 
reasons. This domain of experiences is difficult to verbalize, 
and the patients may have been made more aware of these 
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phenomena and thus were better able to verbalize it at the 
second interview.
Baseline SD correlated with GAF score both syn-
chronically and across occasions. Apart from the 
expected intercorrelations within the EASE and the cor-
relation between EASE and positive symptoms scale at 
follow-up, there were no other significant correlations. 
We have previously shown correlations between EASE, 
and positive symptoms scale and negative symptoms 
scale, respectively; however, the current sample is con-
siderably smaller and diagnostically more homogeneous 
[21].
Notably, SD predicted global symptomatic, but not func-
tional outcome. The functional and symptomatic levels at 
Table 1  Sample profiles and EASE scores at baseline and at 5-years follow-up
We re-analyzed the data using the DSM-IV. Although the sample size changes the results are basically the same
SD standard deviation, GAF-S global assessment of functioning-symptoms, GAF-F global assessment of functioning-function. Significance 
level = 0.05
a McNemar test statistic = (b − c)2/(b + c)
b P value from the exact binomial test evaluating the McNemar test statistic
c Non-Significant, but Chi Square test is not valid due to expected count <5 in many cells
d Test of symmetry 49/7 + 1/3 + 1/1 + 4/2
Baseline 
remainers 
(BA)
Follow-up (FO) Dropouts (DO) Difference FO-BA BA vs FO BA vs DO
Total N 48 48 26
Gender N (%) N (%) N (%) (Kappa) P value. Test for independence
 Male 18 (37.5) 18 (37.5) 8 (30.8) (1.0) 0.62
 Female 30 (62.5) 30 (62.5) 18 (69.2)
Social status N (%) N (%) N (%) Mc  Nemara (Kappa) P  valueb P value. Test for independence
 Married 18 (37.5) 26 (54.2) 12 (46.2) 8 (0.67) 0.008** 0.62
 Alone 30 (62.5) 22 (45.8) 14 (53.8)
Diagnosis Mc  Nemara (Kappa) P  valueb P value. Test for independence
 Non-affective psychosis 30 (62.5) 35 (73.0) 15 (57.7) 2.8 (0.58) 0.18 0.80
 Schizotypy 18 (37.5) 13 (27.0) 11 (42.3)
Highest level of education N (%) N (%) N (%) Bowker’sd (Kappa)
 Primary school or less 17 (35.4) 10 (20.8) 16 (61.5) 10.3 (0.61) 0.41 NSc
 High school 18 (37.5) 25 (52.1) 5 (19.2)
 College 5 (10.4) 6 (12.5) 1 (3.9)
 Started university 4 (8.3) 1 (2.1) 3 (11.5)
 Finished university 4 (8.3) 6 (12.5) 1 (3.9)
Mean (sd) Mean (sd) Mean (sd) Mean (sd) P value. Wilcoxon’s signed rank test for 
equal means
Age in years, mean 25.5 (6.33) 30.1 (6.38) 26.2 (8.13) 4.6 (0.71) <0.0001*** 0.79
Self-disorders
 Total EASE score 20.63 (8.14) 21.92 (7.21) 15.96 (6.30) 1.29 (7.28) 0.40 0.03*
 Domain 1 7.42 (3.18) 7.44 (3.01) 6.31 (2.74) 0.02 (3.23) 0.85 0.15
 Domain 2 7.71 (3.28) 8.73 (2.33) 5.88 (3.04) 1.02 (2.97) 0.03* 0.04*
 Domain 3 2.1 (1.46) 2.1 (1.67) 1.69 (1.46) 0 (1.82) 0.95 0.21
 Domain 4 0.96 (0.99) 1.21 (0.92) 0.50 (0.65) 0.25 (0.98) 0.09 0.06
 Domain 5 2.44 (2.06) 2.44 (1.77) 1.58 (1.30) 0 (1.65) 0.81 0.16
Positive and negative symptoms scales
 Positive symptoms 4.33 (3.72) 4.00 (3.96) 5.11 (4.65) −0.33 (4.35) 0.69 0.75
 Negative symptoms 3.60 (1.83) 5.04 (1.13) 3.15 (1.67) 1.44 (1.84) <0.0001*** 0.27
GAF N = 47 N = 47 N = 26
 GAF-S, mean (N = 47) 37.21 (8.08) 49.87 (9.53) 39.04 (8.41) 12.66 (10.21) <0.0001*** 0.31
 GAF-F, mean (N = 47) 42.4 (10.82) 56.13 (11.32) 44.23 (9.71) 13.72 (11.05) <0.0001*** 0.37
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follow-up may reflect that all patients were hospitalized at 
baseline, but not at follow-up.
With respect to singular items, 9 of the 13 most-fre-
quently rated items at baseline had equal frequencies at 
follow-up.
This study demonstrates a temporal persistence of self-
disorders in schizophrenia-spectrum patients. This persis-
tence is consistent with the view of SD as a fundamental 
feature of schizophrenic psychopathology, as advocated by 
the founders of the concept [2].
We have previously reported from another sample 
that was assessed for SD using a pre-EASE scale, and 
showed a similar pattern of results. The pre-EASE scale 
is not directly comparable to the EASE, because it was 
a post hoc scale constructed due to our evolving interest 
in SD. The reader may compare our Table 3 with Table 1 
from [20]. The pre-EASE scale comprises less than half 
of the items corresponding to the EASE items. Of the 13 
most frequent items rated in this study five items were also 
included in the pre-EASE scale. All these five items were 
also among the most frequently rated items in the previous 
study. All five pre-EASE items were among the nine most-
frequent rated items at both initial and follow-up assess-
ment [20].
Table 2  Correlations between the full EASE scale and the five domains at baseline and follow-up
BA baseline, FO follow-up. Spearman two-tailed
** P < 0.01; * P < 0.05
EASE Domain 1 Domain 2 Domain 3 Domain 4 Domain 5
BA FO BA FO BA FO BA FO BA FO BA FO
EASE BA –
FO 0.479** –
Domain 1 BA 0.706** 0.409** –
FO 0.290* 0.811** 0.439** –
Domain 2 BA 0.862** 0.385** 0.436** 0.201 –
FO 0.538** 0.841** 0.367* 0.588** 0.464** –
Domain 3 BA 0.627** 0.416** 0.183 0.18 0.568** 0.494** –
FO 0.231 0.715** 0.261 0.449* 0.195 0.501** 0.331* –
Domain 4 BA 0.504** 0.330* 0.129 0.146 0.526** 0.341* 0.310* 0.043 –
FO 0.291* 0.504** 0.207 0.269 0.224 0.340* 0.057 0.238 0.450** –
Domain 5 BA 0.716** 0.397** 0.309* 0.155 0.566** 0.443** 0.438** 0.122 0.370** 0.290* –
FO 0.475** 0.658** 0.203 0.337* 0.355* 0.452** 0.380** 0.435** 0.349* 0.456** 0.661** –
Table 3  McNemar’s test for 
equal frequencies at baseline 
and follow-up at item level, for 
the 13 most-frequently rated 
items at baseline
Bold indicates non-equal frequencies between the two times
a P value from the exact binomial test
b McNemar test statistic = (b − c)2/(b + c)
EASE item McNemar2-
sid exact Pa
Frequency at 
baseline
Frequency at 
follow-up
McNemar 
test  statisticb
Thought pressure (item 1.3) 0.3438 0.9 0.81 1.6
Anxiety (item 2.13) 0.625 0.88 0.92 1
Ruminations–obsessions (item 1.6) 0.125 0.85 0.96 3.57
Hypohedonia (item 2.17) 0.0574 0.85 0.69 4.57
Hyperreflectivity (item 2.6) 0.002 0.75 0.96 10
Ambivalence (item 1.9) 1 0.69 0.71 0.08
Diminished initiative (item 2.16) 0.2668 0.69 0.79 1.92
Diminished sense of basic self (item 2.1) 0.0129 0.67 0.88 7.14
Perceptualisation of inner thought (item 1.7) 0.5811 0.65 0.71 0.69
Derealization (item 2.5) 0.0013 0.65 0.35 10.89
Primary self-reference (item 5.1) 1 0.65 0.65 0
Cenestesia (item 3.7) 0.0007 0.58 0.27 11.84
Disorder of short-term memory (item 1.13) 0.5034 0.58 0.5 0.8
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We have elsewhere proposed that SD constitute a phe-
nomenological core of the schizophrenia-spectrum [24, 30].
It must be emphasized that although all patients were psy-
chiatric in-patients at the time of the first assessment (first 
admission), the patient sample is relatively mild at a symp-
tomatic level, see [28].
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